Company / Operating Cash Flow
Caris Life Sciences, Inc. Operating Cash Flow History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$83.2M
FY2025
5-year range
-$276.1M / $83.2M
FY2023-FY2025
Trend
+133.9%
vs FY2024
Sector context
#110 of 163
Health Care
What the data says
At $83M, Caris Life Sciences, Inc.'s operating cash flow ranks #110 of 163 in the Health Care sector. Improved from -$276M to $83M over the past 2 years.
Based on SEC 10-K filings.
$83M in FY2025.
Improved from -$276M to $83M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#110 of 163 in Health CareTop 67% of 163This company $83.2M Sector average $1.0B
▼
-92.0% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow increased 133.9% year-over-year.
- Ranks #110 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $83.2M | +133.9% |
| FY2024 | -$245.2M | +11.2% |
| FY2023 | -$276.1M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026